Plan B Plaintiffs Expect to Face Court’s “Huge Deference” To FDA
This article was originally published in The Tan Sheet
Executive Summary
A recently filed federal lawsuit challenging FDA's approval for OTC distribution of Plan B may present good cause for contesting the drug's approval, but will likely face an uphill battle, the plaintiffs acknowledge